logo
logo

Lumithera Secures Financing To Support Commercial Activities

Lumithera Secures Financing To Support Commercial Activities

03/10/22, 5:41 AM
LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the completion of a debt financing with Leste Clearway and Serengeti Asset Management.

Company Info

Company
Lumi Thera
Additional Info
LumiThera is a commercial-stage medical device company focused on treating people affected by ocular damage and disease including dry age-related macular degeneration, a leading cause of blindness in adults over 65. The company is a leader in the use of PBM for treatment of visual disorders. The company is commercializing the office-based ValedaÒ€ Light Delivery System to be used by eyecare providers as medical treatments. The Valeda Light Delivery System has been granted authorization to use the CE Mark by an EU Notified Body as required for commercial use in the European Union only. Valeda is not approved for use by the Food & Drug Administration (FDA) in the USA. Visit the Company's website at www.lumithera.com. 2022 LumiThera, Inc., All rights reserved. SOURCE LumiThera Inc.